EUVIMEDEUVIMED entdecken
Fallbericht

Remission of Symptoms of Chemotherapy-Refractory Metastatic Insulinoma using Octreotide

S M Longnecker

Drug Intelligence & Clinical Pharmacy · 1988-02 · 22 (2) · 136-138

DOI: 10.1177/106002808802200207 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Drug Intelligence & Clinical Pharmacy, online erschienen am 30.05.2017. Verfasst von S M Longnecker. Beteiligte Einrichtung: Department of Pharmacy, Williamsport Hospital, PA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The symptoms resulting from the hyperinsulinemia of severe refractory metastatic insulinoma were palliated using self-administered divided doses of a long-acting minisomatostatin analog, octreotide. The substance was well tolerated and the attributable side effects were minimal (primarily gastrointestinal complaints). There were significant improvements in peripheral edema, ascites, and serum electrolytes throughout therapy. Serum insulin and glucagon levels were largely unchanged. Computed tomography scans performed during therapy showed stabilization of pancreatic and hepatic disease. Severe, recurrent hypoglycemic episodes due to hyperinsulinemia were reduced both in number and severity for almost a three-month period. This allowed the elimination or reduction of other chronic, supportive medications and improved quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenoma, Islet CellAntineoplastic AgentsDrug ResistanceFemaleGastrinsGlucagonHumansInsulinInsulinomaMiddle AgedNeoplasm MetastasisOctreotidePancreatic NeoplasmsSomatostatin

Substanzen

Antineoplastic AgentsGastrinsInsulinSomatostatinGlucagonOctreotide

Autor:innen und Institutionen

  • Department of Pharmacy, Williamsport Hospital, PA.

Förderung

  • NCRR NIH HHS

Zitieren

APA

Longnecker, S. M. (1988). Remission of Symptoms of Chemotherapy-Refractory Metastatic Insulinoma using Octreotide. Drug Intelligence & Clinical Pharmacy, 22(2), 136-138. https://doi.org/10.1177/106002808802200207

Vancouver

Longnecker SM. Remission of Symptoms of Chemotherapy-Refractory Metastatic Insulinoma using Octreotide. Drug Intelligence & Clinical Pharmacy. 1988;22(2):136-138. doi:10.1177/106002808802200207

BibTeX
@article{Longnecker1988,
  author = {Longnecker, S M},
  title = {Remission of Symptoms of Chemotherapy-Refractory Metastatic Insulinoma using Octreotide},
  journal = {Drug Intelligence & Clinical Pharmacy},
  year = {1988},
  volume = {22},
  number = {2},
  pages = {136--138},
  doi = {10.1177/106002808802200207}
}
Kostenlos starten →